NewAmsterdam Pharma Company NV Overview
NewAmsterdam Pharma Company NV Discounted Cash Flow
DCF Analysis for NAMS.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.86
Current Fair Value
$2.86
↓ 90.6% Downside
Overvalued by 90.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison